Research Article
No access
Published Online: 18 August 2023

Sex Differences in the Association Between Cumulative Use of Cannabis and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults Study

Publication: Cannabis and Cannabinoid Research

Abstract

Background: Cannabis use may impair cognitive function (CF) differently in men and women, due to sex-specific differences in neurobiological mechanisms and environmental risk factors.
Objective: Assess sex differences in the association between cumulative exposure to cannabis and cognitive performance in middle age.
Methods: We studied participants from the Coronary Artery Risk Development in Young Adults (CARDIA) Study, including Black and White men and women 18–30 years old at baseline followed over 30 years. Our cross-sectional analysis of CF scores at year 30 was stratified by sex. We computed categories of cumulative exposure in “cannabis-years” (1 cannabis-year=365 days of use) from self-reported use every 2 to 5 years over 30 years. At years 25 and 30, we assessed CF with the Rey Auditory Verbal Learning Test (verbal memory), the Digit Symbol Substitution Test (processing speed), and the Stroop Interference Test (executive function). At year 30, additional measures included Category and Letter Fluency Test (verbal ability) and the Montreal Cognitive Assessment (global cognition). We computed standardized scores for each cognitive test and applied multivariable adjusted linear regression models for self-reported cumulative cannabis use, excluding participants who used cannabis within 24 h. In a secondary analysis, we examined the association between changes in current cannabis use and changes in CF between years 25 and 30.
Results: By year 30, 1,352 men and 1,793 women had measures of CF; 87% (N=1,171) men and 84% (N=1,502) women reported ever cannabis use. Men had a mean cumulative use of 2.57 cannabis-years and women 1.29 cannabis-years. Self-reported cumulative cannabis use was associated with worse verbal memory in men (e.g., −0.49 standardized units [SU] for ≥5 cannabis-years of exposure; 95% CI=−0.76 to −0.23), but not in women (SU=0.02; 95% CI=−0.26 to 0.29). Other measures of CF were not associated with cannabis. Changes in current cannabis use between years 25 and 30 were not associated with CF in men or women.
Conclusions: Self-reported cumulative cannabis exposure was associated with worse verbal memory in men but not in women. Researchers should consider stratified analyses by sex when testing the association between cannabis and cognition.

Get full access to this article

View all available purchase options and get full access to this article.

Disclaimer

An abstract and a poster have been presented at the SGAIM (Swiss Society of General Internal Medicine) Spring Congress 2021 (https://congress.sgaim.ch/de/archiv-kongresse/2021/fruehjahrskongress/abstracts). Target Journal: Cannabis and Cannabinoids Research—“Call for Papers: Sex and Gender Differences: Focus on Cannabis and Cannabinoids.”

References

1. UNODC. World Drug Report 2022 (United Nations publication, 2022). June 2022. Available from: www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2022.html [Last accessed: December 18, 2022].
2. Rockville MD; Substance Abuse and Mental Health Services, Administration. Results from the 2018 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration. Available from: https://www.samhsa.gov/data/release/2018-nationalsurvey-drug-use-and-health-nsduh-releases [Last accessed: December 18, 2022].
3. Chapman C, Slade T, Swift W, et al. Evidence for sex convergence in prevalence of cannabis use: A systematic review and meta-regression. J Stud Alcohol Drugs 2017;78(3):344–352;
4. Cooper ZD, Craft RM. Sex-dependent effects of cannabis and cannabinoids: A translational perspective. Neuropsychopharmacology 2018;43(1):34–51;
5. Calakos KC, Bhatt S, Foster DW, et al. Mechanisms underlying sex differences in cannabis use. Curr Addict Rep 2017;4(4):439–453;
6. Crane NA, Schuster RM, Fusar-Poli P, et al. Effects of cannabis on neurocognitive functioning: Recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev 2013;23(2):117–137;
7. Nia AB, Mann C, Kaur H, et al. Cannabis use: Neurobiological, behavioral, and sex/gender considerations. Curr Behav Neurosci Rep 2018;5(4):271–280.
8. Francis AM, Bissonnette JN, MacNeil SE, et al. Interaction of sex and cannabis in adult in vivo brain imaging studies: A systematic review. Brain Neurosci Adv 2022;6:23982128211073431;
9. Ketcherside A, Baine J, Filbey F. Sex effects of marijuana on brain structure and function. Curr Addict Rep 2016;3:323–331;
10. Greaves L, Hemsing N. Sex and gender interactions on the use and impact of recreational cannabis. Int J Environ Res Public Health 2020;17(2);
11. Kroon E, Kuhns L, Hoch E, et al. Heavy cannabis use, dependence and the brain: A clinical perspective. Addiction 2020;115(3):559–572;
12. Nader DA, Sanchez ZM. Effects of regular cannabis use on neurocognition, brain structure, and function: A systematic review of findings in adults. Am J Drug Alcohol Abuse 2018;44(1):4–18;
13. Burggren AC, Shirazi A, Ginder N, et al. Cannabis effects on brain structure, function, and cognition: Considerations for medical uses of cannabis and its derivatives. Am J Drug Alcohol Abuse 2019;45(6):563–579;
14. Blest-Hopley G, Giampietro V, Bhattacharyya S. A systematic review of human neuroimaging evidence of memory-related functional alterations associated with cannabis use complemented with preclinical and human evidence of memory performance alterations. Brain Sci 2020;10(2);
15. Meier MH, Caspi A, Knodt AR, et al. Long-term cannabis use and cognitive reserves and hippocampal volume in midlife. Am J Psychiatry 2022;179(5):362–374;
16. Auer R, Vittinghoff E, Yaffe K, et al. Association between lifetime marijuana use and cognitive function in middle age: The Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA Intern Med 2016;176(3):352–361;
17. Solowij N, Jones KA, Rozman ME, et al. Verbal learning and memory in adolescent cannabis users, alcohol users and non-users. Psychopharmacology (Berl) 2011;216(1):131–144;
18. Fried PA, Watkinson B, Gray R. Neurocognitive consequences of marihuana—a comparison with pre-drug performance. Neurotoxicol Teratol 2005;27(2):231–239;
19. Noorbakhsh S, Afzali MH, Boers E, et al. Cognitive function impairments linked to alcohol and cannabis use during adolescence: A study of gender differences. Front Hum Neurosci 2020;14:95;
20. Gur RE, Gur RC. Sex differences in brain and behavior in adolescence: Findings from the Philadelphia Neurodevelopmental Cohort. Neurosci Biobehav Rev 2016;70:159–170;
21. Pope HG, Gruber AJ, Hudson JI, et al. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 2001;58(10):909–915;
22. Lisdahl KM, Price JS. Increased marijuana use and gender predict poorer cognitive functioning in adolescents and emerging adults. J Int Neuropsychol Soc 2012;18(4):678–688;
23. Crane NA, Schuster RM, Gonzalez R. Preliminary evidence for a sex-specific relationship between amount of cannabis use and neurocognitive performance in young adult cannabis users. J Int Neuropsychol Soc 2013;19(9):1009–1015;
24. Pope HG Jr., Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA 1996;275(7):521–527.
25. Pope HG Jr., Jacobs A, Mialet JP, et al. Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychother Psychosom 1997;66(4):179–184;
26. Schnakenberg Martin AM, D'Souza DC, Newman SD, et al. Differential cognitive performance in females and males with regular cannabis use. J Int Neuropsychol Soc 2021;27(6):570–580;
27. Hirst R, Vaughn D, Arastu S, et al. Female sex as a protective factor in the effects of chronic cannabis use on verbal learning and memory. J Int Neuropsychol Soc 2021;27(6):581–591;
28. Crane NA, Schuster RM, Mermelstein RJ, et al. Neuropsychological sex differences associated with age of initiated use among young adult cannabis users. J Clin Exp Neuropsychol 2015;37(4):389–401;
29. Reis JP, Auer R, Bancks MP, et al. Cumulative lifetime marijuana use and incident cardiovascular disease in middle age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Public Health 2017;107(4):601–606;
30. Rosenberg SJ, Ryan JJ, Prifitera A. Rey Auditory-Verbal Learning Test performance of patients with and without memory impairment. J Clin Psychol 1984;40(3):785–787;
31. Beck AT, Feshback S, Legg D. The clinical utility of the digit symbol test. J Consult Psychol 1962;26:263–268;
32. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18(6):643–662.
33. Shao Z, Janse E, Visser K, et al. What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults. Front Psychol 2014;5:772;
34. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53(4):695–699;
35. Yaffe K, Bahorik AL, Hoang TD, et al. Cardiovascular risk factors and accelerated cognitive decline in midlife: The CARDIA study. Neurology 2020;95(7):e839–e846;
36. Zeki Al Hazzouri A, Elfassy T, Sidney S, et al. Sustained economic hardship and cognitive function: The Coronary Artery Risk Development in Young Adults study. Am J Prev Med 2017;52(1):1–9;
37. Gardner RM. The reverse affect test: A new interference task. Percept Mot Skills 1985;60(2):384–386;
38. Broyd SJ, van Hell HH, Beale C, et al. Acute and chronic effects of cannabinoids on human cognition: A systematic review. Biol Psychiatry 2016;79(7):557–567;
39. Jeffers AM, Glantz S, Byers A, et al. Sociodemographic characteristics associated with and prevalence and frequency of cannabis use among adults in the US. JAMA Netw Open 2021;4(11):e2136571;
40. McEvoy CT, Hoang T, Sidney S, et al. Dietary patterns during adulthood and cognitive performance in midlife: The CARDIA study. Neurology 2019;92(14):e1589–e1599;
41. Scott JC, Slomiak ST, Jones JD, et al. Association of cannabis with cognitive functioning in adolescents and young adults: A systematic review and meta-analysis. JAMA Psychiatry 2018;75(6):585–595;
42. Schreiner AM, Dunn ME. Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: A meta-analysis. Exp Clin Psychopharmacol 2012;20(5):420–429;
43. van Rooij FG, Schaapsmeerders P, Maaijwee NA, et al. Persistent cognitive impairment after transient ischemic attack. Stroke 2014;45(8):2270–2274;
44. Håkansson K, Rovio S, Helkala E-L, et al. Association between mid-life marital status and cognitive function in later life: Population based cohort study. BMJ 2009;339:b2462;
45. Leadbeater BJ, Ames ME, Linden-Carmichael AN. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. Addiction 2019;114(2):278–293;
46. Lee SS, Humphreys KL, Flory K, et al. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic review. Clin Psychol Rev 2011;31(3):328–341;
47. Lenroot RK, Gogtay N, Greenstein DK, et al. Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage 2007;36(4):1065–1073;
48. Herlitz A, Nilsson LG, Bäckman L. Gender differences in episodic memory. Mem Cognit 1997;25(6):801–811;
49. Loprinzi PD, Frith E. The role of sex in memory function: Considerations and recommendations in the context of exercise. J Clin Med 2018;7(6);
50. Niklason GR, Rawls E, Ma S, et al. Explainable machine learning analysis reveals sex and gender differences in the phenotypic and neurobiological markers of cannabis use disorder. Sci Rep 2022;12(1):15624;
51. Kavé G, Sapir-Yogev S. Associations between memory and verbal fluency tasks. J Commun Disord 2020;83:105968;
52. Pocuca N, Walter TJ, Minassian A, et al. The effects of cannabis use on cognitive function in healthy aging: A systematic scoping review. Arch Clin Neuropsychol 2021;36(5):673–685;
53. Huo N, Vemuri P, Graff-Radford J, et al. Sex differences in the association between midlife cardiovascular conditions or risk factors with midlife cognitive decline. Neurology 2022;98(6):e623–e632;
54. Levine DA, Gross AL, Briceño EM, et al. Sex differences in cognitive decline among US adults. JAMA Netw Open 2021;4(2):e210169;
55. Rubino T, Parolaro D. Sex-dependent vulnerability to cannabis abuse in adolescence. Front Psychiatry 2015;6:56;
56. de Salas-Quiroga A, García-Rincón D, Gómez-Domínguez D, et al. Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure. Neuropsychopharmacology 2020;45(5):877–886;
57. Burston JJ, Wiley JL, Craig AA, et al. Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated delta-tetrahydrocannabinol exposure. Br J Pharmacol 2010;161(1):103–112;
58. Fattore L, Fratta W. How important are sex differences in cannabinoid action? Br J Pharmacol 2010;160(3):544–548;
59. Hirvonen J, Goodwin RS, Li CT, et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry 2012;17(6):642–649;
60. Laurikainen H, Tuominen L, Tikka M, et al. Sex difference in brain CB1 receptor availability in man. Neuroimage 2019;184:834–842;
61. Normandin MD, Zheng MQ, Lin KS, et al. Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: Assessment of kinetic analysis methods, test-retest reproducibility, and gender differences. J Cereb Blood Flow Metab 2015;35(8):1313–1322;
62. Matheson J, Sproule B, Di Ciano P, et al. Sex differences in the acute effects of smoked cannabis: Evidence from a human laboratory study of young adults. Psychopharmacology (Berl) 2020;237(2):305–316;
63. Arkell TR, Kevin RC, Vinckenbosch F, et al. Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials. Addict Biol 2022;27(2):e13125;
64. Cuttler C, Mischley LK, Sexton M. Sex differences in cannabis use and effects: A cross-sectional survey of cannabis users. Cannabis Cannabinoid Res 2016;1(1):166–175;
65. Bolla KI, Brown K, Eldreth D, et al. Dose-related neurocognitive effects of marijuana use. Neurology 2002;59(9):1337–1343;
66. Gonzalez R, Pacheco-Colón I, Duperrouzel JC, et al. Does cannabis use cause declines in neuropsychological functioning? A review of longitudinal studies. J Int Neuropsychol Soc 2017;23(9–10):893–902;
67. Jakob J, Stalder O, Syrogiannouli L, et al. Association between marijuana use and electrocardiographic abnormalities by middle age: The Coronary Artery Risk Development in Young Adults (CARDIA) study. Addiction 2020;
68. Pletcher MJ, Vittinghoff E, Kalhan R, et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA 2012;307(2):173–181;
69. Ishida JH, Auer R, Vittinghoff E, et al. Marijuana use and estimated glomerular filtration rate in young adults. Clin J Am Soc Nephrol 2017;12(10):1578–1587;
Cite this article as: Pasquier B, Yaffe K, Levine DA, Rana JS, Pletcher MJ, Tal K, Sidney S, Auer R, Jakob J (2023) Sex differences in the association between cumulative use of cannabis and cognitive function in middle age: the coronary artery risk development in young adults study, Cannabis and Cannabinoid Research X:X, 1–17, DOI: 10.1089/can.2022.0343.

Information & Authors

Information

Published In

cover image Cannabis and Cannabinoid Research
Cannabis and Cannabinoid Research
PubMed: 37594767

History

Published online: 18 August 2023

Topics

Authors

Affiliations

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Kristine Yaffe
Department of Psychiatry, Neurology, Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
Deborah A. Levine
Department of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor, Michigan, USA.
Jamal S. Rana
Department of Cardiology, Kaiser Permanente Northern California, Oakland, California, USA.
Mark J. Pletcher
Department of Psychiatry, Neurology, Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
Kali Tal
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Stephen Sidney
Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Reto Auer
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
University General Medicine and Public Health Centre, University of Lausanne, Lausanne, Switzerland.
Julian Jakob* [email protected]
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Department of Paediatrics, University Hospital Bern, Inselspital, Bern, Switzerland.

Notes

*
Address correspondence to: Julian Jakob, MD, Institute of Primary Health Care (BIHAM), University of Bern, Mittelstrasse 43, 3012 Bern, Switzerland. [email protected]

Authors' Contributions

Conception and design of the study were carried out by B.P., R.A., and J.J. Acquisition, analysis, and interpretation of the data were contributed by B.P., K.Y., D.A.L., J.S.R., M.J.P., S.S., R.A., and J.J. Drafting of the article was done by B.P., K.T., R.A., and J.J. Critical revision of the article for important intellectual content was carried out by B.P., K.Y., D.A.L., J.S.R., M.J.P., K.T., S.S., R.A., and J.J. Final approval of the version to be published was taken care by B.P., K.Y., D.A.L., J.S.R., M.J.P., S.S., R.A., and J.J.

Author Disclosure Statement

All authors have no reported conflict of interest. All authors had access to the data.

Funding Information

The CARDIA study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (HHSN268201800005I and HHSN268201800007I), Northwestern University (HHSN268201800003I), University of Minnesota (HHSN268201800006I), and Kaiser Foundation Research Institute (HHSN268201800004I). This article was reviewed by CARDIA for scientific content.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top